Royalty Pharma Plc
Stock Chart, Company Information, and Scan Results
$38.99(as of Dec 30, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Royalty Pharma Plc Company Information, Fundamentals, and Technical Indicators
Stock Price$38.99
Ticker SymbolRPRX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
EmployeesUnknown
CountyUSA
Market Cap$22,790.5M
EBIDTA1,497.8M
P/E Ratio28.52
Forward P/E Ratio11.61
Earnings per Share1.75
Profit Margin47.30%
RSI52.07
Shares Outstanding427.2M
ATR0.70
52-Week High41.24
Volume2,836,929
52-Week Low24.78
Book Value9,620.9M
P/B Ratio2.27
Upper Keltner40.43
P/S Ratio9.29
Lower Keltner37.30
Debt-to-Equity Ratio40.43
Next Earnings Date02/10/2026
Cash Surplus408.1M
Next Ex-Dividend DateUnknown
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Royalty Pharma Plc In Our Stock Scanner
As of Dec 31, 2025
Scan Name: Gravestone DojiScan Type: Candlestick Pattern Scans
As of ---
Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans
As of ---
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.